US Broker Ratings

AnaptysBio, Inc. (ANAB): Exploring a Potential 69.94% Upside in the Biotech Sector

As the biotechnology sector continues to capture investor interest, AnaptysBio, Inc. (NASDAQ: ANAB) emerges as a compelling player with a significant potential upside. Specializing in immunology..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Medical Device Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, focuses on delivering innovative medical device solutions across the globe. While its market presence..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a 193% Potential Upside in the Biotech Sphere

AbCellera Biologics Inc. (NASDAQ: ABCL) is capturing the attention of individual investors with its compelling growth prospects in the dynamic biotechnology industry. Headquartered in Vancouver, Canada,..

Cronos Group Inc. (CRON) Stock Analysis: Assessing the Potential of This Cannabis Player Amidst Market Challenges

For investors keeping a close eye on the volatile cannabis sector, Cronos Group Inc. (NASDAQ: CRON) offers a compelling case study. With its roots firmly planted..

Embecta Corp. (EMBC) Stock Analysis: Seizing a 21% Potential Upside in Healthcare

Embecta Corp. (NASDAQ: EMBC), a key player in the healthcare sector, presents an intriguing opportunity for investors looking to tap into the medical instruments and supplies..

Simulations Plus, Inc. (SLP) Stock Analysis: Unveiling a 37.89% Potential Upside for Investors

Simulations Plus, Inc. (NASDAQ: SLP), a key player in the Health Information Services industry, presents an intriguing investment opportunity with a notable 37.89% potential upside, according..

RxSight, Inc. (RXST) Stock Analysis: Navigating Challenges with Innovative Medical Device Solutions

RxSight, Inc. (NASDAQ: RXST) presents an intriguing opportunity within the healthcare sector, specifically in the medical devices industry. Specializing in innovative solutions for cataract surgery, RxSight..

Replimune Group, Inc. (REPL) Stock Analysis: A 39.53% Upside Potential in Cancer Immunotherapy

Replimune Group, Inc. (NASDAQ: REPL) presents a compelling opportunity for investors with its focus on pioneering oncolytic immunotherapies aimed at revolutionizing cancer treatment. As a clinical-stage..

Evolus, Inc. (EOLS) Stock Analysis: Unveiling a Potential 182% Upside in the Healthcare Sector

Evolus, Inc. (EOLS), a key player in the healthcare sector specializing in aesthetic products, is capturing investor attention with its significant potential upside of nearly 182%...

Savara, Inc. (SVRA) Stock Analysis: Exploring a Potential 120% Upside in the Biotech Sector

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, has been attracting investor attention with its promising potential for significant upside. Currently..

iRadimed Corporation (IRMD) Stock Analysis: Strong Growth in the Medical Device Sector with a 13% Upside Potential

iRadimed Corporation (IRMD), a key player in the medical device sector, stands out with its innovative MRI-compatible equipment and promising financial outlook. Headquartered in Winter Springs,..

Geron Corporation (GERN) Stock Analysis: Potential 203% Upside Amid Biotech Breakthroughs

Geron Corporation (NASDAQ: GERN), a biopharmaceutical entity embedded in the biotechnology sector, has garnered investor attention due to its promising oncology therapeutic developments and significant potential..

GH Research PLC (GHRS) Stock Analysis: Biotech’s Promising 117% Upside in Treating Depression

GH Research PLC (NASDAQ: GHRS), an emerging player in the biotechnology sector, has been making waves with its innovative approach to treating depression, a condition affecting..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Eyeing a 140% Upside with Robust Pipeline Potential

Gyre Therapeutics, Inc. (NASDAQ: GYRE), a promising player in the biotechnology sector, has caught the attention of investors with its substantial growth potential. Operating in the..

CureVac N.V. (CVAC) Investor Outlook: Evaluating the Biotech’s 3.24% Potential Upside

CureVac N.V. (NASDAQ: CVAC), a cutting-edge biopharmaceutical company with a focus on mRNA-based therapies, continues to capture investor attention in the biotechnology sector. Headquartered in Tübingen,..

Immunome, Inc. (IMNM) Stock Analysis: Exploring a 41.22% Potential Upside in Biotech Innovation

Immunome, Inc. (NASDAQ: IMNM) is carving a niche in the healthcare sector, specifically within biotechnology, with a focus on developing targeted cancer therapies. As a clinical-stage..

Weave Communications, Inc. (WEAV): Investor Outlook Reveals 80% Potential Upside

Investors eyeing Weave Communications, Inc. (WEAV) may find the current market conditions intriguing, given the company’s significant upside potential. Specializing in health information services, Weave offers..

Niagen Bioscience, Inc. (NAGE) Investor Outlook: Exploring a Potential 135% Upside

Niagen Bioscience, Inc. (NAGE), a key player in the biotechnology sector, is currently garnering significant attention from investors due to its promising growth potential. Specializing in..

Oculis Holding AG (OCS) Stock Analysis: A Biotech with a Promising 124% Upside Potential

Oculis Holding AG (NASDAQ: OCS), a Switzerland-based biopharmaceutical company, has been making waves in the healthcare sector, particularly in the biotechnology industry. With a market capitalization..

CareDx, Inc. (CDNA) Stock Analysis: Insights into a 41.71% Potential Upside

CareDx, Inc. (CDNA) stands out in the healthcare sector as a pivotal player in the diagnostics and research industry, with a focus on the innovative development..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds